| Symbol |
Name |
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CALB2
|
calbindin 2
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCND1
|
cyclin D1
|
|
CD34
|
CD34 molecule
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CHIA
|
chitinase, acidic
|
|
CLDN2
|
claudin 2
|
|
CLU
|
clusterin
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
F11R
|
F11 receptor
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
IFNG
|
interferon, gamma
|
|
IL33
|
interleukin 33
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT7
|
keratin 7, type II
|
|
LGALS4
|
lectin, galactoside-binding, soluble, 4
|
|
MIR34A
|
microRNA 34a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSX2
|
msh homeobox 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
OCLN
|
occludin
|
|
PAX3
|
paired box 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPP1
|
secreted phosphoprotein 1
|
|
TLR9
|
toll-like receptor 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
VEGFA
|
vascular endothelial growth factor A
|
